A three-nucleotide deletion in the UL97 open reading frame is responsible for the ganciclovir resistance of a human cytomegalovirus clinical isolate

Journal of Virology

Volumn 69, Issue 2, 1995, Pages 796-800

  Baldanti, Fausto ^a   Silini, Enrico ^a   Sarasini, Antonella ^a   Talarico, Christine L ^b   Stanat, Sylvia C ^b   Biron, Karen K ^b   Furione, Milena ^a   Bono, Fulvia ^a   Palù, Giorgio ^c   Gerna, Giuseppe ^a,d  

^a UNIVERSITY OF PAVIA   (Italy)

^b Burroughs Wellcome Co   (United States)

^c UNIVERSITY OF PADOVA   (Italy)

^d UNIVERSITY OF PAVIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CYTOMEGALOVIRUS; DRUG RESISTANCE; ENZYME ACTIVITY; GENE DELETION; HUMAN; HUMAN CELL; NEUTROPHIL; NUCLEOTIDE SEQUENCE; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN DOMAIN; VIRUS ISOLATION; VIRUS MUTANT; VIRUS RESISTANCE; VIRUS STRAIN;

EID: 0028885224     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.69.2.796-800.1995     Document Type: Article

References (21)

1. Biron, K. K., J. A. Fyfe, S. C. Stanat, L. K. Leslie, J. B. Sorrell, C. U. Lambe, and D. M. Coen. 1986. A human cytomegalovirus mutant resistant to the nucleoside analog 9-{[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl}guanine (BW B759U) induces reduced levels of BW B759U triphosphate. Proc. Natl. Acad. Sci. USA 83:8769-8773.
2. Chee, M. S., G. L. Lawrence, and B. G. Barrell. 1989. Alpha-, beta- and gamma herpesviruses encode a putative phosphotranspherase. J. Gen. Virol. 70:1151-1160.
3. Dankner, W. M., D. Scholl, S. C. Stanat, M. Martin, R. L. Sonke, and S. A. Spector. 1990. Rapid antiviral DNA-DNA hybridization assay for human cytomegalovirus. J. Virol. Methods 28:293-298.
4. Drew, W. L., R. C. Miner, D. F. Busch, S. E. Follansbee, J. Gullet, S. G. Mehalko, S. M. Gordon, W. F. Owen, T. R. Matthews, W. C. Bushless, and B. DeArmond. 1991. Prevalence of resistance in patients receiving ganciclovir for serious cytomegalovirus infections. J. Infect. Dis. 163:716-719.
5. Erice, A., S. Chou, K. K. Biron, S. C. Stanat, H. H. Balfour, and M. C. Jordan. 1989. Progressive disease due to ganciclovir-resistant cytomegalovirus in immunocompromised patients. N. Engl. J. Med. 320:289-293.
6. Fleckenstein, B., L. Muller, and J. Collins. 1982. Cloning of the complete human cytomegalovirus genome in cosmids. Gene 18:39-46.
7. Fyfe, J. A., S. A. McKee, and P. M. Keller. 1983. Altered thymidine-thymidylate kinases from strains of herpes simplex virus with modified drug sensitivities to acyclovir and (E)-5-(2-bromovinyl)-2′-deoxyuridine. Mol. Pharmacol. 24:316-323.
8. Gerna, G., F. Baldanti, M. Zavattoni, A. Sarasini, E. Percivalle, and M. G. Revello. 1992. Monitoring of ganciclovir sensitivity of human cytomegalovirus strains coinfecting blood of an AIDS patient by an immediate-early antigen plaque assay. Antiviral. Res. 19:333-345.
9. Gerna, G., M. Parea, E. Percivalle, D. Zipeto, E. Silini, G. Barbarini, and G. Milanesi. 1990. Human cytomegalovirus viremia in HIV-1 seropositive patients at various clinical stages of infection. AIDS 4:1027-1031.
10. Knighton, D. R., J. Zheng, L. F. Ten Eyck, N.-K. Xuong, S. S. Taylor, and J. M. Sowadski. 1991. Structure of a peptide inhibitor bound to the catalytic subunit of cyclic adenosine monophosphate-dependent protein-kinase. Science 253:414-420.
11. Kouzarides, T., A. T. Bankier, S. C. Satchwell, K. Weston, P. Tomlison, and B. G. Barrell. 1987. Sequence and transcription analysis of the human cytomegalovirus DNA polymerase gene. J. Virol. 61:125-133.
12. Littler, E., A. D. Stuart, and M. S. Chee. 1992. Human cytomegalovirus UL97 open reading frame encodes a protein that phosphorylates the antiviral nucleoside analogue ganciclovir. Nature (London) 358:160-162.
13. Lurain, N. S., K. D. Thompson, E. W. Holmes, and G. Sullivan Read. 1992. Point mutations in the DNA polymerase gene of human cytomegalovirus that results in resistance to antiviral agents. J. Virol. 66:7146-7152.
14. Orita, M., Y. Suzuki, T. Sekiya, and K. Hayashi. 1989. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics 5:874-879.
15. Sambrook, J. E., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
16. Sanger, F., S. Nicklen, and A. R. Coulson. 1977. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA 74:5463-5467.
17. Stanat, S. C., J. E. Reardon, A. Erice, M. C. Jordan, W. L. Drew, and K. K. Biron. 1991. Ganciclovir-resistant cytomegalovirus clinical isolates: mode of resistance to ganciclovir. Antimicrob. Agents Chemother. 35:2191-2197.
18. Sullivan, V., K. K. Biron, C. Talarico, S. C. Stanat, M. Davis, L. M. Pozzi, and D. M. Coen. 1993. A point mutation in the human cytomegalovirus DNA polymerase gene confers resistance to ganciclovir and phosphonylmethoxy-alkyl derivatives. Antimicrob. Agents Chemother. 37:19-25.
19. Sullivan, V., C. L. Talarico, S. C. Stanat, M. Davis, D. M. Coen, and K. K. Biron. 1992. A protein kinase homologue controls phosphorylation of ganciclovir in human cytomegalovirus-infected cells. Nature (London) 358:162-164.
20. Wang, T. S.-F., S. W. Wong, and D. Korn. 1989. Human DNA polymerase α: predicted functional domains and relationships with viral DNA polymerases. FASEB J. 3:14-21.
21. Zipeto, D., M. G. Revello, E. Silini, M. Parea, E. Percivalle, M. Zavattoni, G. Milanesi, and G. Gerna. 1992. Development and clinical significance of a diagnostic assay based on the polymerase chain reaction for detection of human cytomegalovirus DNA in blood samples from immunocompromised patients. J. Clin. Microbiol. 30:527-530.